Gut Microbiota in Metabolic-associated Fatty Liver Disease and in Other Chronic Metabolic Diseases

• 作 者: Winston Hernández-Ceballos Jacqueline Cordova-Gallardo Nahum Mendez-Sanchez
• 机 构: Plan of Combined Studies in Medicine (PECEM-MD/PhD),Faculty of Medicine,National Autonomous Universi
• 出 处: 临床与转化肝病杂志（英文版）
• 发表日期: 2021年2期
• 关键词: Metabolic-associated fatty liver disease Metabolic-associated stea-tohepatitis G

The gut microbiome plays a key role in the health-disease balance in the human body. Although its composition is unique for each person and tends to remain stable through-out lifetime, it has been shown that certain bacterial patterns may be determining factors in the onset of certain chronic metabolic diseases, such as type 2 diabetes mellitus (T2DM), obesity, metabolic-associated fatty liver disease (MAFLD), and metabolic syndrome. The gut-liver axis embodies the close relationship between the gut and the liver; disturbance of the normal gut microbiota, also known as dysbiosis, may lead to a cascade of mechanisms that modify the epithelial properties and facilitate bacterial translocation. Regulation of gut microbiota is fundamental to maintaining gut integ-rity, as well as the bile acids composition. In the present review, we summarize the current knowledge regarding the microbiota, bile acids composition and their association with MAFLD, obesity, T2DM and metabolic syndrome.